Healthcare -
Biotechnology - NASDAQ - US
$ 20.72
-1.57 %
$ 1.8 B
Market Cap
-4.58
P/E
TVTX - GROSS PROFIT
Gross Profit TVTX - Travere Therapeutics, Inc.
134 M
LAST VALUE
-22.14%
2 YEAR CAGR
-3.36%
5 YEAR CAGR
0.00%
10 YEAR CAGR